Journal: Oncology reports
Article Title: High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.
doi: 10.3892/or.2019.7269
Figure Lengend Snippet: Figure 1. Graphical representation of the experimental workflow and analysis followed. The total cell extract from three cervical cancer cell lines [HeLa (HPV18+), SiHa (HPV16+), C33A (HPV‑)] and normal cervical keratinocytes (HCK1T) was collected and analyzed by SDS‑PAGE, following the GeLC‑MS/MS protocol. The bands were excised from the gel and cut into small pieces where in‑gel trypsinization was performed. The extracted peptides were then analyzed by LC‑MS/MS and the resulting spectra were translated into protein lists. After differential expression analysis, an extensive literature mining was performed in order to shortlist the proteins based on existing studies on cancer and cervical cancer, in particular. The datasets and shortlisted proteins from this study can be used for clinical validation (e.g. immunohistochemistry, multiple reaction monitoring mass spectrometry) and functional investigation with the aim to develop novel biomarkers and drug targets. LC‑MS/MS, liquid chromatography‑tandem mass spectrometry.
Article Snippet: HeLa (HPV 18+), SiHa (HPV 16+) and C33A (HPV-) cervical cancer cell lines, were purchased from the American Type Culture Collection (ATCC) (Manassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Gibco/Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 1% penicillin‐streptomycin at 37 ̊C in 5% CO2 as previously described (11).
Techniques: Quantitative Proteomics, Biomarker Discovery, Immunohistochemistry, Targeted Proteomics, Mass Spectrometry, Functional Assay